How DiME’s New Pediatric Rare Disease Project Could Make Clinical Trials Faster
The Digital Medicine Society (DiME) launched a new set of FDA-aligned digital measures to standardize how outcomes are tracked in pediatric rare disease trials. The framework aims to make trials faster and more efficient, giving researchers and drugmakers a practical roadmap for developing new therapies for children who often have no effective treatment options.
MedCity FemFwd: Why Women’s Health Is a Scalable Sector
In this episode, we’re joined by Anna Jeter, co-founder and chief regulatory officer of AOA Dx. We dive into AOA Dx’s recent report on women's health exits.
Optimizing Care Pathways: The Next Frontier in Rehab Performance
We cannot wait for CMS to hand us perfect blueprints for rehab. The time is now for rehab leaders to define what optimized care looks like, build these pathways using evidence and outcomes data, and then aggressively demonstrate that our services are the most effective way to align with the new strategic direction of healthcare.
Can AI Bridge the Gaps in Women’s Healthcare? A Responsible Path Forward
We are only beginning to see how AI can impact women's health. As these technologies advance and become more integrated into healthcare workflows, we can expect more personalized care pathways that address women's needs across different life stages.
Premise-Crossover Merger: Inside the $2B Push for a New Employer Health Model
Premise Health and Crossover Health are merging to create a nearly $2 billion company. The partners plan to scale advanced primary care — an integrated bundle of primary care, behavioral health, pharmacy services and care navigation — for large self-insured employers.